Kilitch Drugs shareholders approve key resolutions at 33rd AGM

Kilitch Drugs (India) Limited held its 33rd Annual General Meeting (AGM) on Friday, September 26, 2025, via video conferencing, commencing at 9:30 AM and concluding at 9:48 AM. Shareholders adopted the audited standalone and consolidated financial statements for the year ended March 31, 2025.

Key resolutions passed included the re-appointment of Mr. Bhavin Mehta as a director and the re-appointment of Mr. Mukund Mehta as managing director for another five-year term. Shareholders also approved the continuation of Mr. Vasudev Krishna Murti as a non-executive independent director upon attaining 75 years of age.

Additionally, the appointment of M/s Deep Shukla & Associates as secretarial auditor and the ratification of remuneration for the cost auditor were approved. A special resolution to waive off PLI given to executive directors also passed. The full voting results and scrutineer's report are pending release on the company's website.